title: [Surgical treatment of Mycobacterium avium complex lung disease].
abstract: Mycobacterium avium complex (MAC) lung disease is the most common nontuberculous mycobacterial lung disease in Japan and is difficult to treat. Multidrug regimen employing clarithromycin, rifampicin, and ethambutol is not a panacea. Pulmonary resection may be beneficial to patients whose disease is predominantly localized to one lung and who can tolerate resectional surgery under the following circumstances: poor response to drug therapy, the development of macrolide-resistant MAC disease, or the presence of hemoptysis. Resectional surgery for MAC lung disease can achieve favorable treatment outcome. However, this type of surgery is associated with a relatively high morbidity and should be performed by experienced hands.
authors.affiliation: Section of Chest Surgery, Fukujuji Hospital, Japan Anti-Tuberculosis Association.
authors.forename: Yuji
authors.initials: Y
authors.lastname: Shiraishi
mesh_terms: D006801:Humans; D015270:Mycobacterium avium-intracellulare Infection / Q000601:surgery*; D011013:Pneumonectomy; D014397:Tuberculosis, Pulmonary / Q000601:surgery*